Members of the promoter group of clean science & technology will transfer 2,00,38,000 equity shares, representing 18.86% of the paid-up share capital, via inter-se gift on or after June 6, 2026. The transactions involve Ashok Ramnarayan Boob, Asha Ashok Boob, and Nilima Krishnakumar Boob transferring shares to ARB Business Trust, AAB Business Trust, and Alaknanda Business Trust. The transfer aims to streamline the family's assets and businesses, and the aggregate holding of the promoter and promoter group remains unchanged before and after the transaction.

The transfers fall under the exemption provided by Regulation 10(1)(a)(ii) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As the transactions are gifts, no consideration is involved. The company confirmed receipt of the information from the acquirers on June 1, 2026.

Shareholding Pattern

The disclosure details the shift in shareholding between donors and donees within the promoter group. The following table outlines the proposed transfers:

Transaction Details

The acquisition involves equity shares of Re. 1 each. The acquirers have confirmed compliance with the applicable disclosure requirements under Chapter V of the Takeover Regulations. Prior to the transaction, ARB Business Trust held 100 shares (0.00%), which will increase to 33,00,100 shares (3.11%) post-transfer. AAB Business Trust held 100 shares (0.00%), which will increase to 1,01,00,100 shares (9.50%). Alaknanda Business Trust held 100 shares (0.00%), which will increase to 58,00,100 shares (5.46%).

Conversely, Ashok Ramnarayan Boob's holding will decrease from 36,71,510 shares (3.45%) to 3,71,510 shares (0.35%). Mrs. Asha Ashok Boob's holding will decrease from 1,01,98,392 shares (9.60%) to 98,392 shares (0.09%). Mrs. Nilima Krishnakumar Boob's holding will decrease from 67,29,986 shares (6.33%) to 91,986 shares (0.09%).

A note in the disclosure states that Asha Ashok Boob is in the process of an additional inter-se transfer, pursuant to which she proposes to receive a gift of 8,38,000 shares from Mrs. Nilima Krishnakumar Boob. Upon completion of that transfer, her total shareholding will increase to 9,36,392 shares, representing 0.88% of the total share capital.

Clean Science & Technology has announced its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors, at their meeting held on May 14, 2026, approved the financial results and recommended a final dividend of ₹4 per equity share of face value ₹1 each for FY26, subject to shareholder approval at the ensuing Annual General Meeting. The statutory auditors, Price Waterhouse Chartered Accountants LLP, issued an unmodified audit opinion on both standalone and consolidated financial results. In compliance with Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company also confirmed the publication of the audited financial results in Business Standard (English edition) and Loksatta (Marathi edition) on May 15, 2026, as well as the upload of the audio recording of its Q4 FY26 Earnings Conference Call on its official website.

Standalone Financial Performance

On a standalone basis, the company reported revenue from operations of ₹815 crore for FY26, a decline from ₹922 crore in FY25. Standalone profit after tax (PAT) for the year stood at ₹251 crore, a decrease of 14% from ₹292 crore in the previous year. Despite the revenue decline, standalone EBITDA margins remained resilient at 44.3% for FY26, compared to 44.0% in FY25. For the quarter ended March 31, 2026, standalone revenue from operations was ₹197 crore, lower than ₹245 crore in Q4 FY25, while standalone PAT stood at ₹58.10 crore compared to ₹78.60 crore in the corresponding quarter of the previous year. On a sequential basis, standalone revenue improved by 6% from ₹185 crore in Q3 FY26, while EBITDA rose by 22% quarter-on-quarter. EBITDA margins recovered to 44.7% in Q4 FY26 from 42.59% in Q4 FY25. During Q4 FY26, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for FY26, resulting in a reversal of earlier provisions and lower employee benefits expense for the quarter.

The following table summarises the key standalone and consolidated financial metrics:

Consolidated Financial Performance

On a consolidated basis, the company reported revenue from operations of ₹957 crore for FY26, a marginal decrease from ₹967 crore in FY25. Consolidated PAT for the year stood at ₹230 crore, a decline of 13% from ₹266 crore in FY25. Consolidated EBITDA stood at ₹355 crore with margins at 37.7%, compared to ₹388 crore and 40.8% in the prior year. The consolidated results include the financial performance of four wholly owned subsidiaries: Clean Fino-Chem Limited, Clean Science Private Limited, Clean Aromatics Private Limited, and Clean Organics Private Limited. The Group is exclusively engaged in the manufacturing of organic chemicals, constituting a single primary operating segment as per Ind AS 108.

The standalone statement of assets and liabilities as at March 31, 2026 reflects total assets of ₹17,839.51 million, compared to ₹16,048.84 million as at March 31, 2025. Total equity stood at ₹16,456.44 million, with other equity at ₹16,350.16 million. On a consolidated basis, total assets were ₹17,829.00 million as at March 31, 2026, against ₹16,077.60 million in the prior year, with total equity at ₹15,837.71 million.

Earnings Per Share

The standalone basic earnings per share (EPS) for FY26 stood at ₹23.64, compared to ₹27.51 in FY25. Diluted EPS was ₹23.63 for FY26 against ₹27.50 in FY25. For Q4 FY26, standalone basic EPS was ₹5.47 and diluted EPS was ₹5.46. On a consolidated basis, basic EPS for FY26 was ₹21.61 and diluted EPS was ₹21.60, compared to ₹24.88 each in FY25.

Corporate Actions and Other Developments

The Board recommended a final dividend of ₹4 per equity share of face value ₹1 each for FY26, implying a total payout ratio of 25% for the year. The book closure and dividend payment date will be determined later. The Board also approved an additional investment of ₹200 crore in one or more tranches in Clean Fino-Chem Limited, a wholly owned subsidiary. The company incurred a total capex of approximately ₹220 crore during FY26, primarily towards investment in its subsidiary. During FY26, 10,040 equity shares of ₹1 each fully paid-up were allotted upon exercise of vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021). The Board also approved the re-appointment of M/s CNK JBMS & Associates as Internal Auditors and M/s Dhananjay V. Joshi & Associates as Cost Auditors, both for FY 2026-27.

Regulatory Disclosures and Earnings Call

Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Clean Science & Technology submitted copies of the newspaper advertisement published in Business Standard (English edition) and Loksatta (Marathi edition) on May 15, 2026, confirming the audited financial results for the quarter and financial year ended March 31, 2026. The company also confirmed the upload of the audio recording of its Q4 FY26 Earnings Conference Call, held on May 14, 2026, on the company's official website. Both submissions were made by Ruchita Vij, Company Secretary and Compliance Officer.

Source: Company/INE227W01023